首页> 外文期刊>Journal of Clinical Microbiology >High-Level Rifampin Resistance Correlates with Multiple Mutations in the rpoB Gene of Pulmonary Tuberculosis Isolates from the Afghanistan Border of Iran
【24h】

High-Level Rifampin Resistance Correlates with Multiple Mutations in the rpoB Gene of Pulmonary Tuberculosis Isolates from the Afghanistan Border of Iran

机译:高水平的利福平耐药性与来自伊朗阿富汗边界的肺结核分离株的rpoB基因中的多个突变相关

获取原文
           

摘要

The aim of this study was to investigate the significance of multiple mutations in the rpoB gene as well as predominant nucleotide changes and their correlation with high levels of resistance to rifampin (rifampicin) in Mycobacterium tuberculosis isolates that were randomly collected from the sputa of 46 patients with primary and secondary cases of active pulmonary tuberculosis from the southern region (Afghanistan border) of Iran where tuberculosis is endemic. Drug susceptibility testing was performed using the CDC standard conventional proportional method. DNA extraction, rpoB gene amplification, and DNA sequencing analysis were performed. Thirty-five (76.09%) isolates were found to have multiple mutations (two to four) in the rpoB (β-subunit) gene. Furthermore, we demonstrate that the combination of mutations with more prevalent nucleotide changes were observed in codons 523, 526, and 531, indicating higher frequencies of mutations among patients with secondary infection. In this study, 76.08% (n = 35) of all isolates found to have mutation combinations involving nucleotide changes in codons 523 (GGG→GCG), 531 (TCG→TTG or TTC), and 526 (CAC→CGC, TTC, AAC, or CAA) demonstrated an association with higher levels of resistance to rifampin (MIC, ≥100 μg/ml).
机译:这项研究的目的是调查 rpoB 基因中多个突变的重要性以及主要的核苷酸变化,以及它们与结核分枝杆菌的高水平抗药性相关/ em>分离物是从伊朗南部地区(结核病流行地区)的46例原发和继发性活动性肺结核患者的痰中随机收集的。使用CDC标准常规比例法进行药物敏感性测试。进行DNA提取, rpoB 基因扩增和DNA测序分析。发现35个(76.09%)分离株在 rpoB (β亚基)基因中具有多个突变(2至4个)。此外,我们证明在密码子523、526和531中观察到具有更多普遍核苷酸变化的突变组合,表明继发感染患者的突变频率更高。在这项研究中,发现所有分离株的76.08%( n = 35)具有涉及密码子523(GGG→GCG),531(TCG→TTG或TTC)和526( CAC→CGC,TTC,AAC或CAA)证明与对利福平的更高抗药性(MIC,≥100μg/ ml)相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号